Symptom burden of outpatients with malignant head and neck cancer

Introduction Therapeutic interventions in head and neck oncology often have a negative impact on quality of life. In this monocentric, prospective cohort study, we investigated the symptom burden of patients with malignant head and neck cancer in our outpatient follow-up clinic.

Material and Methods During our regular follow-up visits, patients received a standardized and validated questionnaire (MIDOS-2) to assess relevant symptoms. Primary study objectives were symptom frequency and intensity of the 10 most common symptoms in patients with head and neck cancer. Additional objectives were to derive a need for therapeutical intervention.

Results From 07/01/2019 to 12/31/2019, 227 patients with malignant head and neck tumors were surveyed. The three most common symptoms were fatigue (52.4%), weakness (37.9%), and anxiety (34.8%). Constipation (10.6%), nausea (6.2%), and vomiting (4.0%) occurred least frequently. On average [Mean], patients scored a symptom intensity of 3.23 points (SD ±3.36).

The symptoms with the highest intensities were fatigue (MW 0.73; SD ±0.818) weakness (MW 0.47, SD ±0.673) and pain (M 0.44, SD ±0.678). Therapeutic intervention should be applied above a moderate symptom intensity. This occurred for fatigue in 17.2%, for pain in 10.6%, and for lack of appetite and anxiety in 7.9% each. Rarely, the need for intervention arose for the symptoms of nausea and vomiting (0.4% each).

Summary The results show that a large proportion (76.6%) of patients with head and neck tumors have a low symptom burden. Symptom burdens requiring intervention are most common for symptoms of fatigue and pain and least common for nausea and vomiting.

 

MissingLinkText

Conflict of Interest

The author declares that there is no conflict of interest.

Publication History

Article published online:
24 May 2022